Thursday May 25th 2017

Posts Tagged ‘liberation treatment’

Going abroad for Lemtrada for MS is reminiscent of CCSVI

Going abroad for Lemtrada for MS is reminiscent of CCSVI

There are many who suffer from multiple sclerosis (MS) in the United States who are upset with the FDA for not approving of the drug Alemtuzumab, otherwise known as Lemtrada. To the point where a petition was made to fight the ruling. This, on top of Genzyme appealing the [Read More]

CCSVI 2013: ‘debunking,’ spin, and legal drama

CCSVI 2013: ‘debunking,’ spin, and legal drama

If there were a drinking game that called for taking a shot whenever the term chronic cerebrospinal venous insufficiency—or CCSVI—appeared in 2013 in a headline alongside “debunked” or “death knell,” we all would have been plastered well before New Year’s Eve. [Read More]

Wolfville couple adamant Liberation treatment offers hope

Wolfville couple adamant Liberation treatment offers hope

Wolfville area resident Christopher Alkenbrack makes no bones about it. While scientists argue about the success of the so-called Liberation therapy for Multiple Sclerosis, Alkenbrack passionately promotes what worked for him. Alkenbrack is the president of the National [Read More]

 Page 1 of 243  1  2  3  4  5 » ...  Last » 

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]